04:36 AM EST, 12/13/2024 (MT Newswires) -- CG Oncology ( CGON ) said late Thursday it priced a public offering of 8 million shares at $28 per share, with 7.3 million shares being offered by the company and 700,000 shares being offered by an existing stockholder.

The gross proceeds are expected to be $204.4 million, the company said, adding that it will not receive proceeds from the sale of shares by the selling stockholder.

The offering is expected to close on Dec. 16.

Additionally, the company said it has granted underwriters a 30-day option to purchase up to 1.2 million additional shares at the offering price.